Which company produces acalatinib and how to use it?

Acalabrutinib, English nameAcalabrutinib, is an innovative drug developed by AstraZeneca, a world-renowned pharmaceutical company. As a new generation of highly selective Bruton's tyrosine kinase (BTK) inhibitor, acotinib has demonstrated excellent efficacy in the treatment of hematological tumors such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), bringing new treatment hope to patients around the world.

The use of acotinib must strictly follow medical advice. The following is general medication guidance:

1. Dosage and frequency: The usual recommended dose is 100 mg taken orally every 12 hours, that is, twice a day, with a 12-hour interval between doses. Patients should take medication at a fixed time every day to ensure stable blood concentration.

2. How to take: Acotinib should be swallowed whole and avoid chewing, breaking or dissolving. Can be taken with water for better swallowing.

3. Note: Patients should pay close attention to their own reactions while taking acotinib. If serious adverse reactions occur, they should seek medical treatment in time and inform the doctor of the drugs they are using. In addition, acotinib may interact with some drugs. Please inform your doctor about all your medications before taking it.

4. Dose adjustment: If the patient needs to interrupt or terminate treatment due to adverse reactions, this should be done under the guidance of a doctor. The doctor will develop a personalized medication plan based on the patient's specific situation.

In short, acotinib, as an innovative drug from AstraZeneca, has demonstrated significant advantages in the treatment of specific hematological tumors. However, its use must be strictly followed by medical instructions to ensure medication safety and maximum efficacy. If patients have any questions or discomfort during use, they should communicate with their doctor in time and seek professional advice. Currently, acotinib has both the original version of the drug and an affordable generic version. Patients should choose according to their needs.